JP2019517572A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517572A5 JP2019517572A5 JP2018564983A JP2018564983A JP2019517572A5 JP 2019517572 A5 JP2019517572 A5 JP 2019517572A5 JP 2018564983 A JP2018564983 A JP 2018564983A JP 2018564983 A JP2018564983 A JP 2018564983A JP 2019517572 A5 JP2019517572 A5 JP 2019517572A5
- Authority
- JP
- Japan
- Prior art keywords
- here
- chemotherapeutic agent
- naphthalen
- yloxy
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002246 antineoplastic agent Substances 0.000 claims 10
- 229940127089 cytotoxic agent Drugs 0.000 claims 9
- 239000013066 combination product Substances 0.000 claims 8
- 229940127555 combination product Drugs 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- DGPGXHRHNRYVDH-UHFFFAOYSA-N 4-[2-(5-methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine Chemical compound N=1N(C=2C=C3C=CC=CC3=CC=2)C(C)=CC=1OCCN1CCOCC1 DGPGXHRHNRYVDH-UHFFFAOYSA-N 0.000 claims 4
- 229960001756 oxaliplatin Drugs 0.000 claims 4
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 229930012538 Paclitaxel Natural products 0.000 claims 3
- 229940123237 Taxane Drugs 0.000 claims 3
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 3
- 229960004316 cisplatin Drugs 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229960001592 paclitaxel Drugs 0.000 claims 3
- 229910052697 platinum Inorganic materials 0.000 claims 3
- 239000000047 product Substances 0.000 claims 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 3
- SHRYQZBTQDMGLZ-UHFFFAOYSA-N 4-[2-(5-methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine;hydrochloride Chemical compound Cl.N=1N(C=2C=C3C=CC=CC3=CC=2)C(C)=CC=1OCCN1CCOCC1 SHRYQZBTQDMGLZ-UHFFFAOYSA-N 0.000 claims 2
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000009702 cancer cell proliferation Effects 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 229940044683 chemotherapy drug Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382258.8 | 2016-06-06 | ||
| EP16382258 | 2016-06-06 | ||
| PCT/EP2017/063614 WO2017211763A1 (en) | 2016-06-06 | 2017-06-05 | Use of sigma receptor ligands in cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019517572A JP2019517572A (ja) | 2019-06-24 |
| JP2019517572A5 true JP2019517572A5 (enExample) | 2020-07-16 |
| JP7094231B2 JP7094231B2 (ja) | 2022-07-01 |
Family
ID=56134287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018564983A Active JP7094231B2 (ja) | 2016-06-06 | 2017-06-05 | がんにおけるシグマ受容体リガンドの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190142840A1 (enExample) |
| EP (1) | EP3463339B1 (enExample) |
| JP (1) | JP7094231B2 (enExample) |
| CN (1) | CN109310672B (enExample) |
| AR (1) | AR108682A1 (enExample) |
| ES (1) | ES2969815T3 (enExample) |
| TW (1) | TW201808300A (enExample) |
| WO (1) | WO2017211763A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1781618T3 (pl) * | 2004-08-27 | 2013-03-29 | Esteve Labor Dr | Inhibitory receptora sigma |
| GB0907973D0 (en) * | 2009-05-08 | 2009-06-24 | Modern Biosciences Plc | Combination therapy |
| EP2292236A1 (en) * | 2009-08-14 | 2011-03-09 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| CA2781744C (en) | 2009-11-25 | 2017-11-07 | Laboratorios Del Dr. Esteve, S.A. | 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts |
| SG182628A1 (en) | 2010-02-04 | 2012-08-30 | Esteve Labor Dr | 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates |
| EP2388005A1 (en) * | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
-
2017
- 2017-06-05 EP EP17726968.5A patent/EP3463339B1/en active Active
- 2017-06-05 ES ES17726968T patent/ES2969815T3/es active Active
- 2017-06-05 CN CN201780034885.9A patent/CN109310672B/zh active Active
- 2017-06-05 TW TW106118544A patent/TW201808300A/zh unknown
- 2017-06-05 US US16/306,946 patent/US20190142840A1/en not_active Abandoned
- 2017-06-05 AR ARP170101529A patent/AR108682A1/es unknown
- 2017-06-05 WO PCT/EP2017/063614 patent/WO2017211763A1/en not_active Ceased
- 2017-06-05 JP JP2018564983A patent/JP7094231B2/ja active Active